A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Clinical trial NCT07029711 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07029711
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2026-12-02
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.